Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot, Randomized, Double Blind, Placebo Controlled Study to Evaluate an Immune System Modulator Nutritional Supplement for the Prevention of Infections in Cancer Patients Receiving Oncologic Treatment During the COVID-19 Pandemia.

NCT05080920 is registered in ClinicalTrials.gov with Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares as lead sponsor.

NCT NCT05080920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05080920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot, Randomized, Double Blind, Placebo Controlled Study to Evaluate an Immune System Modulator Nutritional Supplement for the Prevention of Infections in Cancer Patients Receiving Oncologic Treatment During the COVID-19 Pandemia.
Lead sponsor
Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares
Phase
Not applicable
Overall status
Completed
Start date
October 28, 2020
Completion date
December 31, 2022
Enrollment
109 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, covid19, infections